These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3112568)

  • 1. Effect of fagaronine on chromosome breaks and loss in Drosophila melanogaster.
    Pérez-Chiesa Y; Cintrón CN; Rodríguez A
    Mutat Res; 1987 Aug; 188(4):307-9. PubMed ID: 3112568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic effect of fagaronine in Drosophila melanogaster.
    Pérez-Chiesa Y; Cintrón CN
    Mutat Res; 1986 Mar; 173(3):193-6. PubMed ID: 3081800
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of genotoxicity of the indenoisoquinoline analogues of fagaronine and nitidine in Drosophila melanogaster.
    Pérez-Chiesa Y; Narváez Z
    Mutat Res; 1993 Apr; 301(4):207-12. PubMed ID: 7680753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of mutagenicity of benzo[c]phenanthridine alkaloids in somatic cells of Drosophila melanogaster: comparison with 7,12-dimethylbenz[a]anthracene and chrysene.
    Pérez-Chiesa Y; Rodríguez A
    Mutat Res; 1993 Feb; 298(4):277-83. PubMed ID: 7678164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids.
    Pezzuto JM; Antosiak SK; Messmer WM; Slaytor MB; Honig GR
    Chem Biol Interact; 1983 Mar; 43(3):323-39. PubMed ID: 6337734
    [No Abstract]   [Full Text] [Related]  

  • 6. The antileukemic alkaloid fagaronine and the human K 562 leukemic cells: effects on growth and induction of erythroid differentiation.
    Comoë L; Jeannesson P; Trentesaux C; Desoize B; Jardillier JC
    Leuk Res; 1987; 11(5):445-51. PubMed ID: 3472016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II.
    Larsen AK; Grondard L; Couprie J; Desoize B; Comoe L; Jardillier JC; Riou JF
    Biochem Pharmacol; 1993 Oct; 46(8):1403-12. PubMed ID: 8240389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer.
    Benoist H; Comoe L; Joly P; Carpentier Y; Desplaces A; Dufer J
    Cancer Immunol Immunother; 1989; 30(5):289-94. PubMed ID: 2624922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylamine and derivatives: cytotoxicity without mutagenicity in cellular genetic systems.
    Fahmy OG; Fahmy MJ
    Chem Biol Interact; 1970 Dec; 2(4):331-48. PubMed ID: 5002638
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of topoisomerase I function by nitidine and fagaronine.
    Wang LK; Johnson RK; Hecht SM
    Chem Res Toxicol; 1993; 6(6):813-8. PubMed ID: 8117920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-mutagenic effect of tannic acid on ring-X chromosome loss induced by mitomycin C in sperm cells of Drosophila melanogaster.
    Cunha KS; Reguly ML; Gimmler-Luz MC; Santos JH; Lehmann M; de Andrade HH
    Mutat Res; 1994 Jul; 308(2):143-8. PubMed ID: 7518041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term assays to predict carcinogenicity. Assays for genetic activity in Drosophila melanogaster.
    Würgler FE; Ramel C; Moustacchi E; Carere A
    IARC Sci Publ; 1986; (83):351-93. PubMed ID: 3114138
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutagenicity of hycanthone in Drosophila melanogaster.
    Knaap AG; Kramers PG
    Mutat Res; 1974 Jan; 22(1):55-62. PubMed ID: 4367140
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutagenicity of 7,12-dimethylbenz[a]anthracene and some other aromatic mutagens in Drosophila melanogaster.
    Zijlstra JA; Vogel EW
    Mutat Res; 1984 Feb; 125(2):243-61. PubMed ID: 6422284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of chromosome aberrations by cis-platinum(II) diamminodichloride in Drosophila melanogaster.
    Brodberg RK; Lyman RF; Woodruff RC
    Environ Mutagen; 1983; 5(3):285-97. PubMed ID: 6406216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of chromosome aberrations by chemical mutagens in neural ganglia of Drosophila melanogaster.
    De Marco A; Polani S
    Mutat Res; 1983 Jan; 107(1):93-102. PubMed ID: 6186912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of site-specific inhibition of human DNA topoisomerase I by fagaronine and ethoxidine. Relation to DNA binding.
    Fleury F; Sukhanova A; Ianoul A; Devy J; Kudelina I; Duval O; Alix AJ; Jardillier JC; Nabiev I
    J Biol Chem; 2000 Feb; 275(5):3501-9. PubMed ID: 10652345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ratio of induced recessive lethals to ring-X loss has prognostic value in terms of functionality of chemical mutagens in Drosophila melanogaster.
    Zijlstra JA; Vogel EW
    Mutat Res; 1988 Sep; 201(1):27-38. PubMed ID: 2458528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent mutagenicity of urethan (ethyl carbamate) gas in Drosophila melanogaster.
    Nomura T
    Cancer Res; 1979 Oct; 39(10):4224-7. PubMed ID: 113087
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the antitumor drugs 3-nitrobenzothiazolo[3,2-alpha]quinolinium and fagaronine on nucleic acid and protein synthesis.
    Torres CA; Báez A
    Biochem Pharmacol; 1986 Feb; 35(4):679-85. PubMed ID: 3511918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.